Stage of Chronic Kidney Disease Predicts Seroconversion after Hepatitis B Immunization: Earlier is Better

American Journal of Kidney Diseases

Volumn 42, Issue 6, 2003, Pages 1184-1192

  DaRoza, Gerald ^a   Loewen, Andrea ^a   Djurdjev, Ognjenka ^a   Love, Janet ^a   Kempston, Cathy ^a   Burnett, Shelley ^a   Kiaii, Mercedeh ^a   Taylor, Paul A ^a   Levin, Adeera ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chronic kidney disease (CKD); Hepatitis B; Levels of kidney function; Predictors; Seroconversion

Indexed keywords

CREATININE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EVALUATION; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PROSPECTIVE STUDY; SEROCONVERSION; VACCINATION;

EID: 0345690072     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.08.019     Document Type: Article

References (59)

1. Fabrizi F, Martin P: Hepatitis B virus infection in dialysis patients. Am J Nephrol 20:1-11, 2000
2. Ribot S, Rothstein M, Goldblat M, et al: Duration of hepatitis B surface antigenemia (HBsAg) in hemodialysis patients. Arch Intern Med 139:178-180, 1979
3. London WT, Drew JS, Lustbader ED, et al: Host responses to hepatitis B infection in patients in a chronic hemodialysis unit. Kidney Int 12:51-58, 1977
4. Stevens CE, Alter HJ, Taylor PE, et al: Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 311:496-501, 1984
5. Buti M, Viladomiu L, Jardi R, et al: Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 12:144-147, 1992
6. Fleming SJ, Moran DM, Cooksley WG, et al: Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 22:251-257, 1991
7. Majdan M, Polz M, Ksiazek A, et al: [The response to the hepatitis B virus vaccine in patients undergoing hemodialysis and peritoneal-dialysis - Personal experience]. Przegl Lek 52:307-310, 1995
8. Bel'eed K, Wright M, Eadington D, et al: Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 78:538-540, 2002
9. Tokars JI, Alter MJ, Miller E, et al: National surveillance of dialysis associated diseases in the United States - 1994. ASAIO J 43:108-119, 1997
10. Oddone EZ, Cowper PA, Hamilton JD, et al: A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. Health Serv Res 28:97-121, 1993
11. Lewis-Ximenez LL, Oliveira JM, Mercadante LA, et al: Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron 87:19-26, 2001
12. Lefton CK: Hepatitis B infects 14 patients in Texas dialysis unit. Nephrol News Issues 8:8, 18, 24, 1994
13. Brown J, Peters V: Improved hepatitis B vaccination rates in ESRD patients in California. Adv Ren Replace Ther 7:S95-S99, 2000 (suppl 1)
14. Centers for Disease Control and Prevention: Outbreaks of hepatitis B virus infection among hemodialysis patients - California, Nebraska, and Texas, 1994. JAMA 275:1394-1395, 1996
15. Tanaka S, Yoshiba M, Iino S, et al: A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. Kidney Int 48:1972-1978, 1995
16. Gonzalez-Griego M, Penton E, Delgado G, et al: [Impact of an anti-hepatitis B virus (HBV) immunization program in patients undergoing dialysis in Havana, Cuba]. Invest Clin 41:237-244, 2000
17. Miller ER, Alter MJ, Tokars JI: Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 33:356-360, 1999
18. Fontaine H, Pol S [Prevention and treatment of viral hepatitis in renal insufficiency conditions]. Nephrologie 22: 339-347, 2001
19. Taal MW, van Zyl-Smit R: Cost-effectiveness of hepatitis B vaccination in haemodialysis patients. S Afr Med J 91:340-344, 2001
20. Rangel MC, Coronado VG, Euler GL, et al: Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Semin Dial 13:101-107, 2000
21. Charest AF, McDougall J, Goldstein MB: A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36:976-982, 2000
22. el-Reshaid K, al-Mufti S, Johny KV, et al: Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 12:223-234, 1994
23. Marangi AL, Giordano R, Montanaro A, et al: Hepatitis B virus infection in chronic uremia: Long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 23:537-542, 1994
24. Poux JM, Ranger S, Lagarde C, et al: Efficacy of intradermal injection of recombinant hepatitis B vaccine in dialysis patients. Nephrol Dial Transplant 9:1213-1214, 1994
25. Propst T, Propst A, Lhotta K, et al: Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 32:1041-1045, 1998
26. Milkowski A, Wyrwicz G, Kubit P, et al: [Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients]. Przegl Lek 57:628-634, 2000
27. Rault R, Freed B, Nespor S, et al: Efficacy of different hepatitis B vaccination strategies in patients receiving hemodialysis. ASAIO J 41:M717-M719, 1995
28. Lombardi M, Pizzarelli F, Righi M, et al: Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 61:266-268, 1992
29. Girndt M, Kohler H: Hepatitis B virus infection in hemodialysis patients. Semin Nephrol 22:340-350, 2002
30. Kruger S, Muller-Steinhardt M, Kirchner H, et al: A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am J Kidney Dis 38:1264-1270, 2001
31. Girndt M, Sester M, Sester U, et al: Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78:S206-S211, 2001
32. Sester U, Sester M, Hank M, et al: T-Cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 15:1217-1223, 2000
33. Kramer J, Stachowski J, Barth C, et al: Genetic regulation of the impaired immune response to hepatitis-B vaccine associated with low TCR density in end stage renal disease patients: Contribution of complement C4 and factor B alleles. Immunol Lett 59:13-19, 1997
34. Pesanti EL: Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 15:813-832, 2001
35. Descamps-Latscha B, Chatenoud L: T Cells and B cells in chronic renal failure. Semin Nephrol 16:183-191, 1996
36. Jadoul M, Goubau P: Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol 58:301-304, 2002
37. Sezer S, Ozdemir FN, Guz G, et al: Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc 32:607-608, 2000
38. Fernandez E, Betriu MA, Gomez R, et al: Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 11:1559-1563, 1996
39. Pozzilli P, Arduini P, Visalli N, et al: Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30:817-819, 1987
40. Vagelli G, Calabrese G, Mazzotta A, et al: More about response to hepatitis B vaccine in hemodialysis patients. Nephron 49:171, 1988
41. Steketee RW, Ziarnik ME, Davis JP: Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin. Am J Epidemiol 127:772-782, 1988
42. Navarro JF, Teruel JL, Mateos ML, et al: Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection. Am J Nephrol 16:95-97, 1996
43. Peces R, de la Torre M, Alcazar R, et al: Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 29:239-245, 1997
44. Hollinger FB: Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 87:S36-S40, 1989 (suppl 3a)
45. Bommer J, Grussendorf M, Jilg W, et al: Vaccination against hepatitis B in patients with renal insufficiency. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21:300-305, 1985
46. Dukes CS, Street AC, Starling JF, et al: Hepatitis B vaccination and booster in predialysis patients: A 4-year analysis. Vaccine 11:1229-1232, 1993
47. Seaworth B, Drucker J, Starling J, et al: Hepatitis B vaccines in patients with chronic renal failure before dialysis. J Infect Dis 157:332-337, 1988
48. Agarwal SK, Irshad M, Dash SC: Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure. J Assoc Physicians India 47:183-185, 1999
49. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for CKD. Am J Kidney Dis 39:S1-S246, 2002 (suppl 1)
50. Fabrizi F, Di Filippo S, Marcelli D, et al: Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis. Nephron 72:536-543, 1996
51. Levin A: Identification of patients and risk factors in chronic kidney disease-Evaluating risk factors and therapeutic strategies. Nephrol Dial Transplant 16:S57-S60, 2001 (suppl 7)
52. Jungers P, Massy ZA, Nguyen-Khoa T, et al: Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 16:2357-2364, 2001
53. Lameire N, Van Biesen W: The pattern of referral of patients with end-stage renal disease to the nephrologist-A European survey. Nephrol Dial Transplant 14:S16-S23, 1999 (suppl 6)
54. Alter MJ, Favero MS, Francis DP: Cost benefit of vaccination for hepatitis B in hemodialysis centers. J Infect Dis 148:770-771, 1983
55. Kohler H: Hepatitis B immunization in dialysis patients - Is it worthwhile? Nephrol Dial Transplant 9:1719-1720, 1994
56. Caillat-Zucman S, Gimenez JJ, Albouze G, et al: HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients. Kidney Int Suppl 41:S157-S160, 1993
57. Pol S, Legendre C, Mattlinger B, et al: Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients. J Hepatol 11:385-387, 1990
58. Anandh U, Thomas PP, Shastry JC, et al: A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin. J Assoc Physicians India 48:1061-1063, 200
59. Sennesael JJ, Van der Niepen P, Verbeelen DL: Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 40:121-128, 1991